CStone Pharmaceuticals
Anny-Yue Yin has over 10 years of experience in the pharmaceutical industry. Anny-Yue started their career at Genentech in 2007, where they worked as a Senior Biostatistician until 2010. Anny-Yue then joined Roche as an Associate Director Biostatistics, where they worked for seven years. In 2017, Anny-Yue Yin joined CStone Pharmaceuticals as the VP and Head of Biometrics.
Anny-Yue Yin received their Bachelor of Science (B.S.) in Applied Mathematics from Peking University in 2002. Anny-Yue pursued further education and completed their Ph.D. in Biostatistics at The Johns Hopkins University from 2002 to 2007.
CStone Pharmaceuticals
CStone is a biopharmaceutical company focused on developing and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and worldwide. Established at the end of 2015, CStone has assembled a world-class management team with extensive experience in innovative drug development, clinical research, and commercialization. With a strategic emphasis on immuno-oncology combination therapies, the Company has built an oncology-focused pipeline of 16 drug candidates, including 5 late-stage candidates at pivotal trials or registration stages. With an experienced team, a rich pipeline, a robust clinical development-driven business model and substantial funding, CStone’s vision is to become a world-renowned biopharmaceutical company that is leading the way to conquering cancer.